COVID-19 survivors face increased mental health risks up to a year later
People who have had mild or serious COVID-19 infections have a significantly higher chance of experiencing mental health problems, according to new research from the Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System.
Valdez to help promote diversity in health research
Ryan Valdez, a graduate student working with Petra Levin in Arts & Sciences, won a $105,033 grant from the National Institutes of Health (NIH) to promote diversity in health-related research.
Diabetes, metabolic syndrome in mice treated with novel class of compounds
Researchers at Washington University School of Medicine have shown, in mice, that a new class of compounds they developed can improve several aspects of metabolic syndrome. Such conditions often lead to cardiovascular disease, the leading cause of death worldwide.
Electronic signature tool available to campus community
WashU Information Technology is offering a tool, DocuSign, that provides a secure method for collecting electronic signatures on documents shared between colleagues within or outside the university. The method can save time and resources.
Boyer elected to orthopedic surgery board
Martin I. Boyer, MD, the Carol B. and Jerome T. Loeb Professor of Orthopaedic Surgery at the School of Medicine, has been named a director-elect for the American Board of Orthopaedic Surgery.
Washington University participates in clinical trial of Moderna omicron booster
Washington University School of Medicine is participating in a nationwide phase 2 clinical trial to evaluate whether an investigational omicron-specific booster of the Moderna COVID-19 vaccine is safe and capable of eliciting a strong immune response.
Ponder to study protein-ion binding
Chemist Jay Ponder, in Arts & Sciences, received a $152,775 supplemental award from the National Institutes of Health (NIH) for protein-ion binding research.
Researchers unravel omicron’s secrets to better understand COVID-19
In two recent studies, researchers at Washington University School of Medicine found evidence that the omicron variant of the virus that causes COVID-19 causes less severe disease than previous variants — at least in rodents — but that many antibody-based therapies may not be effective against it.
Reichhardt to continue cystic fibrosis research
Courtney Reichhardt in Arts & Sciences received a $110,000 postdoc-to-faculty transition award from the Cystic Fibrosis Foundation to continue researching the disease.
Register for Spring into Motion wellness challenge
The Office of Human Resources is offering Spring into Motion, a wellness challenge running from March 7-May 1. Registration begins Feb. 18.
View More Stories